Current Treatment Options in Gastroenterology

, Volume 2, Issue 4, pp 313–319 | Cite as

Prophylaxis for stress-related gastrointestinal hemorrhage

  • Tamir Ben-Menachem
  • Robert S. Bresalier
Article

Opinion statement

The incidence of clinically important stress-related gastrointestinal hemorrhage (SRGIH) has decreased without the use of prophylaxis. This decline is probably attributable to improved care in the modern intensive care unit: aggressive correction of hypovolemia, adequate respiratory support, maintenance of tissue perfusion, and improved nutritional support. The majority of patients admitted to intensive care units are not at risk of developing clinically important SRGIH. Patients who are at high risk for SRGIH, and who may, therefore, benefit from prophylaxis, are those with at least one of the factors listed in Table 1. Antacids, histamine type 2-receptor antago-nists (H2 RA), proton pump inhibitors, and sucralfate all provide comparable protection from SRGIH. The choice of pharmacologic agent for prophylaxis therefore depends on other considerations, such as cost, side effects, and ease of administration. In this regard, it is still unclear whether these prophylactic medications increase the inci-dence of nosocomial pneumonia when administered to intensive care unit patients. Antacids may pose the greatest risk for developing pneumonia, followed by H2RA, and sucralfate. More research is necessary to resolve this important issue. Pharmacologic prophylaxis for SRGIH is cost effective only in high- risk populations. Based on existing literature, the cost of using of routine prophylaxis is prohibitive for at least two-thirds of patients admitted to intensive care units who are at low risk of SRGIH. When prophylaxis is administered to high-risk patients, the cost-per-averted-bleeding episode for sucralfate is lower than for other medications.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Bresalier RS. The clinical significance and pathophysi-ology of stress-related gastric mucosal hemorrhage. J Clin Gastroenterol. 1991, 13(Suppl 2):S35-S42.PubMedGoogle Scholar
  2. 2.
    Schuster DP, Rowley H, Feinsten S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984, 76:623–630.PubMedCrossRefGoogle Scholar
  3. 3.
    Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit: A randomized, controlled, single-blind study. Ann Intern Med. 1994, 121:568–575. Large propective randomized trial of stress ulcer prophylaxis which includes a no-treatment group for comparison. Reviews the pitfalls of designing and interepreting such studies.PubMedGoogle Scholar
  4. 4.
    Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994, 330:377–381. Evaluates the incidence of stress-related gastrointestinal hemor-rhage and impact of individual risk factors in the modern ICU.PubMedCrossRefGoogle Scholar
  5. 5.
    Devlin JW, Ben-Menachem T, Ulep SK, et al. Stress ulcer prophylaxis in medical ICU patients: annual utilization in relation to the incidence of endoscopi-cally proven stress ulceration. Ann Pharmacother. 1998, 32:869–874.PubMedCrossRefGoogle Scholar
  6. 6.
    Tryba M. Prophylaxis of stress ulcer bleeding, A Meta-Analysis. J Clin Gastroenterol. 1991, 13(Suppl 2):S44-S55.PubMedGoogle Scholar
  7. 7.
    Cook DJ, Witt LG, Cook RJ, et al. Stress ulcer prophy-laxis in the critically ill: A meta-analysis. Am J Med. 1991, 91:519–527.PubMedCrossRefGoogle Scholar
  8. 8.
    Peterson, WL. Prevention of upper gastrointestinal bleeding. N Engl J Med. 1994, 330:428–429.PubMedCrossRefGoogle Scholar
  9. 9.
    Bresalier RS. Sucralfate for prevention of acute gastrointestinal bleeding. In Sucralfate: From Basic Science to Bedside. Edited by Holander D and Tytgat GNJ.New York: Plenum Press; 1995:289–301.Google Scholar
  10. 10.
    Cook D, Reeve BK, Guyatt GH et al. Stress ulcer prophy-laxis in critically ill patients. Resolving discordant meta-analyses. JAMA. 1996, 275:308–314. Meta-analysis which examines the efficacy of various agents for prevention of stress-related bleeding, and their impact on development of nosocomial pneumonia in the ICU.PubMedCrossRefGoogle Scholar
  11. 11.
    Lacroix J, Infante-Rivard C, Jenicek M, et al. Prophylaxis of upper gastro-intestinal bleeding in intensive care units: A meta-analysis. Crit Care Med. 1989, 17:862–869.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilcox CM, Spenney JG. Stress ulcer prophylaxis in medical patients: Who, what and how much? Am J Gastroenterol. 1988, 83:1199–1211.PubMedGoogle Scholar
  13. 13.
    Pinilla JC, Oleniuk FH, Reed D, et al. Does antacid prophylaxis prevent upper gastrointestinal bleeding in critically ill patients? Crit Care Med 1985, 13:646–650.PubMedCrossRefGoogle Scholar
  14. 14.
    van den Berg B, van Blankenstein M. Prevention of stress-induced upper gastro-intestinal bleeding by cimetidine in patients on assisted ventilation. Digestion. 1985, 31:1–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Peura DA, Johnson LF. Cimetidine for prevention and treatment of gastroduodenal mucosal lesions in patients in an intensive care unit. Ann Intern Med. 1985, 103:173–177.PubMedGoogle Scholar
  16. 16.
    Lacroix J, Infant-Rivard C, Gauthier M, et al.. Upper gastrointestinal tract bleeding acquired in a pediatric intensive care unit: Prophylaxis trial with cimetidine. J Pediatr. 1986, 108:1015–1018.PubMedCrossRefGoogle Scholar
  17. 17.
    Groll A, Simon JB, Wigle RD, et al.. Cimetidine prophy-laxis for gastrointestinal bleeding in an intensive care unit. Gut. 1986, 27:135–140.PubMedGoogle Scholar
  18. 18.
    Karlstadt RG, Iberti TJ, Silverstein J, et al. Comparison of cimetidine and placebo for the prophylaxis of upper gastro-intestinal bleeding due to stress-related gastric mucosal damage in the intensive care unit. J Intensive Care Med. 1990, 5:26–32.Google Scholar
  19. 19.
    Reusser P, Gyr K, Scheidegger D, et al. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: Current incidence and effect of acid-reducing prophylaxis. Crit Care Med. 1990, 18:270–273.PubMedCrossRefGoogle Scholar
  20. 20.
    Ruiz-Santana S, Ortiz E, Gonzalez B, et al. Stress-induced gastroduodenal lesions and total parenteral nutrition in critically ill patients: Frequency, compli-cations, and the value of prophylactic treatment. A prospective, randomized study. Crit Care Med. 1991, 19:887–891.PubMedCrossRefGoogle Scholar
  21. 21.
    Cook DJ, Pearl RG, Cook RJ, et al. The incidence of clinically important bleeding in ventilated patients. J Intensive Care Med. 1991, 6:167–174.Google Scholar
  22. 22.
    Lacroix J, Nadeau D, Laberge S, et al. Frequency of upper gastrointestinal bleeding in a pediatric intensive care unit. Crit Care Med. 1992, 20:35–42.PubMedCrossRefGoogle Scholar
  23. 23.
    Cochran EB, Phelps SJ, Tolley EA, et al. Prevalence of, and risk factors for, upper gastrointestinal tract bleeding in critically ill pediatric patients. Crit Care Med. 1992, 20:1519–1523.PubMedCrossRefGoogle Scholar
  24. 24.
    Martin LF, Booth FV, Karlstadt RG et al. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia. Crit Care Med. 1993, 21:19–30.PubMedCrossRefGoogle Scholar
  25. 25.
    Pingleton SK, Hadzima SK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983, 11:13–17.PubMedCrossRefGoogle Scholar
  26. 26.
    Zandstra DF, Stoutenbeck CP. The virtual absence of stress-related bleeding in ICU patients receiving prolonged mechanical ventilation without any prophylaxis. A prospective cohort study. Intensive Care Med 1994, 20:335–340.PubMedCrossRefGoogle Scholar
  27. 27.
    Driks MR, Craven DE, Celli BR, et al. Nosocomial pneumonia in intubated patients given sucralfate as compared with antacids or histamine type 2 blockers. N Engl J Med. 1987, 317:1376–1382.PubMedCrossRefGoogle Scholar
  28. 28.
    Ben-Menachem T, McCarthy BD, Fogel R et. al.Prophylaxis for stress-related gastrointestinal hemor-rhage: A cost effectiveness analysis. Crit Care Med 1996, 24:338–345. Cost effectiveness analysis which highlights the importance of determining the incidence of stress-related hemorrhage in different ICU populations and the risk of nosocomial pneu-monia for the agents prescribed as prophylaxis. Methodology of the analysis is described in detail, allowing the reader to experiment with assumptions which may differ from those used by the authors.PubMedCrossRefGoogle Scholar
  29. 29.
    Craven DE, Kunches LM, Kilinsky V, et al. Risk factors for pneumonia and fatality in patients receiving continuous mechanical ventilation. Am Rev Respir Dis. 1986, 133:792–796.PubMedGoogle Scholar
  30. 30.
    Reusser P, Zimmerli W, Scheidegger D, et al. Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation. J Infect Dis. 1989, 160:414–421.PubMedGoogle Scholar
  31. 31.
    Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechan-ical ventilation. N Engl J Med. 1998, 339:791–797.CrossRefGoogle Scholar
  32. 32.
    Phillips JO, Metzler MH, Palmieri TL, et al. A prospec-tive study of simplified omeprazole suspension for the prophylaxis of stress-related mucsosal damage. Crit Care Med. 1996, 24:1793–1800.PubMedCrossRefGoogle Scholar
  33. 33.
    Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated patients. J Trauma. 1998, 44:527–533.PubMedCrossRefGoogle Scholar
  34. 34.
    Skala I, Mareckova O, Vitko S, et al. Prophylaxis of acute gastroduodenal bleeding after renal trans-plantation. Transpl Int. 1997, 10:375–378.PubMedCrossRefGoogle Scholar
  35. 35.
    Barie PS, Hariri RJ. Therapeutic use of omeprazole for refactory stress-induced gastric mucosal hemorrhage. Crit Care Med. 1992, 20:899–901.PubMedCrossRefGoogle Scholar
  36. 36.
    MacDougall BRD, Bailey RJ, Williams R. H 2 -receptor antagonists and antacids in the prevention of acute gas-trointestinal haemorrhage in fulminant hepatic failure: two controlled trials. Lancet. 1977, 1:617–619.PubMedCrossRefGoogle Scholar
  37. 37.
    Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding. N Engl J Med. 1978, 298:1041–1045.PubMedCrossRefGoogle Scholar
  38. 38.
    Zinner MJ, Zuidema GD, Smith Pl et. al. The prevention of upper gastrointestinal tract bleeding in an inten-sive care unit. Surg Gynecol Obstet 1981, 153:214–220.PubMedGoogle Scholar
  39. 39.
    Bresalier RS, Grendell JH, Cello JP, et al.: Sucralfate suspension versus titrated antacid for the prevention of stress-related gastrointestinal hemorrhage in critically ill patients. Amer J Med 1987, 83(Suppl 38):110–116.PubMedCrossRefGoogle Scholar
  40. 40.
    Ohta S, Yukioka T, Ohta S, et al. Hemostasis with Endo-scopic hemoclipping for severe gastrointestinal bleed-ing in critically ill patients. Am J Gastroenterol. 1996, 91:701–704.PubMedGoogle Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Tamir Ben-Menachem
    • 1
  • Robert S. Bresalier
    • 1
  1. 1.Gastroenterology DepartmentHenry Ford Health Sciences CenterDetroit

Personalised recommendations